GoodRx Launches New $39 Per Month Weight Loss Telemedicine Subscription, Unveils Industry-Leading Introductory Cash Price of $199 Per Month for Ozempic® and Wegovy®
GoodRx Holdings, Inc. - Class A (GDRX)
Company Research
Source: Business Wire
End-to-end GLP-1 care done right: only FDA-approved medications and savings that set a new standard for weight management treatment SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced two major initiatives to make FDA-approved GLP-1 medications more widely available. First, the launch of GoodRx for Weight Loss, a telemedicine subscription that connects consumers to licensed healthcare providers for affordable weight management treatment. Second, in partnership with Novo Nordisk, a new introductory cash price of $199 per month for Ozempic® (semaglutide) and Wegovy® (semaglutide) injection pens, available to GoodRx users.This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251117268209/en/GoodRx for Weight Loss“GoodRx is scaling a consumer-first model for affordable GLP-1 treatment,” said Wendy Barnes, President and CEO of GoodRx. “We’re committed
Show less
Read more
Impact Snapshot
Event Time:
GDRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GDRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GDRX alerts
High impacting GoodRx Holdings, Inc. - Class A news events
Weekly update
A roundup of the hottest topics
GDRX
News
- Why The Narrative Around GoodRx Is Shifting Amid New Partnerships And Industry Uncertainty [Yahoo! Finance]Yahoo! Finance
- Give the Gift of the Movies With Cyber Monday Taking 20% Off a Regal Cinemas Gift Card [CNET News]CNET News
- We Tested (and Loved) the Casabrews Espresso Machine. It's Just $119 for Cyber Monday [CNET News]CNET News
- Adorn Your Wrist With a 45mm Pixel Watch 3 for Just $200 This Black Friday [CNET News]CNET News
- Does turkey actually make you sleepy? Here's the truth about the post-food snooze [FOX News]FOX News
GDRX
Earnings
- 11/4/25 - Beat
GDRX
Sec Filings
- 11/17/25 - Form 4
- 11/10/25 - Form 4
- 11/10/25 - Form 4
- GDRX's page on the SEC website